Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. (IDRA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IDRA · as of Jun 9, 2026
Key Statistics
Explore Idera Pharmaceuticals, Inc. Data
idra stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 55.6%
Competitors & Peers
idra competitorsIDRA
ALLK
ANGN
ANPC
FRLN
GMTXStock Performance
Full HistoryAbout Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. is a biopharmaceutical company committed to the research, development, and commercialization of medicines addressing rare diseases within the United States. A key offering …
what is idera pharmaceuticals, inc. · idra stock overview · idera pharmaceuticals, inc. company profile · who is idera pharmaceuticals, inc. ceo · idra NASDAQ · idera pharmaceuticals, inc. headquarters · idera pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Idera Pharmaceuticals, Inc. (IDRA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 25, 1996. As of the latest trading session, IDRA stock price is $0.42, with a market capitalization of $0. The stock has returned -95.19% over the past 12 months and -94.58% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Idera Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Idera Pharmaceuticals, Inc. reported revenue of — and net income of -$23.4M. For detailed data — including Idera Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Idera Pharmaceuticals, Inc. (IDRA) stock price is $0.42. The stock is traded on NASDAQ under the ticker symbol IDRA. The 52-week range is $0.42 – $16.00.